John E Bishop sold $76k of ARDX
See Remarks at ARDELYX, INC.. 19,750 shares at an average of $3.86, traded Aug 21, 2026, filed Aug 25, 2026.
Score components
- +15RoleOfficer
- +8Trade size$76k at market
- 0Share of holdings soldSold 5.9% of holdings
- +15Cluster8 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001308911-26-000007, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 21, 2026 | SOpen-market sale Common Stock | -17,281 | $3.86 | $67k | 319,564 | Aug 25, 2026 |
| Aug 21, 2026 | SOpen-market sale Common Stock | -2,469 | $3.86 | $9,523 | 317,095 | Aug 25, 2026 |
Related signals
Other insiders at ARDELYX, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 53Moderate | ARDELYX, INC. | Michael Raab President & CEO | $226k 58,574 shares | -3% | |
| 36Weak | ARDELYX, INC. | Laura A Williams Chief Patient Officer | $41k 10,739 shares | -3% | |
| 35Weak | ARDELYX, INC. | Mike Kelliher Chief Business Officer | $30k 7,758 shares | -2% | |
| 36Weak | ARDELYX, INC. | Eric Duane Foster Chief Commercial Officer | $33k 8,562 shares | -2% | |
| 30Weak | ARDELYX, INC. | Joseph James Reilly See Remarks | $15k 3,982 shares | -3% | |
| 37Weak | ARDELYX, INC. | James Parker Brady Chief Human Resources Officer | $58k 15,136 shares | -6% | |
| 37Weak | ARDELYX, INC. | Susan Hohenleitner Chief Financial Officer | $6,009 1,558 shares | -1% | |
| 2Weak | ARDELYX, INC. | Michael Raab President & CEO | $211k 41,668 shares | -2% | |
| 11Weak | ARDELYX, INC. | Laura A Williams Chief Patient Officer | $490k 81,898 shares | -18% | |
| 11Weak | ARDELYX, INC. | Michael Raab President & CEO | $236k 41,666 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.